Basit öğe kaydını göster

dc.contributor.authorJannuzzi, Ayşe Tarbın
dc.contributor.authorOtsuka, Masami
dc.contributor.authorFujita, Mikako
dc.contributor.authorTuyun, Amaç Fatih
dc.contributor.authorYıldırım, Hatice
dc.contributor.authorYıldız, Mahmut
dc.contributor.authorBayrak, Nilüfer
dc.contributor.authorMataracı-Kara, Emel
dc.contributor.authorRadwan, Mohamed Osman
dc.date.accessioned2022-07-04T15:54:50Z
dc.date.available2022-07-04T15:54:50Z
dc.date.issued2022
dc.identifier.citationYıldırım H., Yıldız M., Bayrak N., Mataracı-Kara E., Radwan M. O. , Jannuzzi A. T. , Otsuka M., Fujita M., Tuyun A. F. , "Promising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking", PHARMACEUTICALS, cilt.15, sa.5, 2022
dc.identifier.issn1424-8247
dc.identifier.otherav_c916bf5c-b02d-42d2-b4f6-34dd324783ad
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/184666
dc.identifier.urihttps://doi.org/10.3390/ph15050586
dc.identifier.urihttps://www.mdpi.com/1424-8247/15/5/586/pdf
dc.description.abstractIn the present study, we designed and synthesized thiolated VK3 analogs (VK3a-g) along with an extensive antimicrobial study. After the evaluation of the antibacterial and antifungal activity against various bacterial and fungal strains, we presented an initial structure-activity relationship study on these VK3 analogs. In particular, four thiolated VK3 analogs exhibited superior biological potency against some Gram-positive bacterial strains, including Staphylococcus aureus (ATCC (R) 29213) and Enterococcus faecalis (ATCC (R) 29212). Next, all thiolated VK3 analogs were evaluated for their potential of cell growth inhibition on the NCI-60 cancer cell lines panel. This screening underlined that the thiolated VK3 analogs have no visible cytotoxicity on different cancer cell lines. The selected two thiolated VK3 analogs (VK3a and VK3b), having minimal hemolytic activity, which also have the lowest MIC values on S. aureus and E. faecalis, were further evaluated for their inhibition capacities on biofilm formation after evaluating their potential in vitro antimicrobial activity against each of the 20 clinically obtained resistant strains of Staphylococcus aureus. VK3b showed excellent antimicrobial activity against clinically resistant S. aureus isolates. Furthermore, the tested molecules showed nearly two log(10) reduction in the viable cell count at six hours according to the time kill curve studies. Although these molecules decreased biofilm attachment about 50%, when sub-MIC concentrations were used these molecules increased the percentage of biofilm formation. The molecular docking of VK3a and VK3b in S. aureus thymidylate kinase was conducted in order to predict their molecular interactions. VK3a and VK3b exhibited excellent lead-likeness properties and pharmacokinetic profiles that qualify them for further optimization and development. In conclusion, since investigating efficient novel antimicrobial molecules is quite difficult, these studies are of high importance, especially in the present era of antimicrobial resistance.
dc.language.isoeng
dc.subjectPharmacology (medical)
dc.subjectKİMYA, TIP
dc.subjectKimya
dc.subjectTemel Bilimler (SCI)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectBiyokimya
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectChemistry (miscellaneous)
dc.subjectGeneral Chemistry
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.titlePromising Antibacterial and Antifungal Agents Based on Thiolated Vitamin K3 Analogs: Synthesis, Bioevaluation, Molecular Docking
dc.typeMakale
dc.relation.journalPHARMACEUTICALS
dc.contributor.department, ,
dc.identifier.volume15
dc.identifier.issue5
dc.contributor.firstauthorID3422612


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster